As used in this subchapter:
-
(1) “Board” means the State and Public School Life and Health Insurance Board;
-
(2) “Choosing Wisely Initiative” means the initiative established by the American Board of Internal Medicine Foundation that seeks to advance a national dialogue on avoiding wasteful or unnecessary medical tests, treatments, and procedures;
-
(3) “Emerging therapies” means therapeutic services that have not historically been covered but for which new evidence may demonstrate therapeutic enhancements or opportunities for cost avoidance, or both;
-
(4) “Evidence” means peer-reviewed objective studies of emerging therapies; and
-
(5) “Regenerative injection therapy” means a nonsurgical orthopedic treatment performed by injecting into a joint or soft tissue a substance that stimulates the growth of normal cells and tissues for the purpose of strengthening or repairing a painful or injured joint or connective tissue.